Outlook on the Nutraceuticals Sector for 2024-2025

We sought insights from industry experts deeply versed in marketplace dynamics to discuss significant trends and developments in business, regulation, science, and the market that the industry should focus on in the upcoming year. Their insights span a range of issues, highlighting common themes such as state regulations, global supply chain strategies, and women’s health.

Michael McGuffin, President of the American Herbal Products Association (AHPA), noted that 2024 brought considerable external pressures on the industry from both state and federal critics who often confuse legal, safe dietary supplements with illegal products. He emphasized the importance of industry unity to capitalize on the opportunities the new political landscape offers, particularly in distinguishing dietary supplements from other products. AHPA is advocating for legislative changes to strengthen the FDA’s ability to crack down on illegal products disguised as dietary supplements, thereby protecting consumers and maintaining industry integrity.

Duffy MacKay, Senior VP of Dietary Supplements at the Consumer Healthcare Products Association (CHPA), reflected on the FDA’s ongoing concerns about supplements with hidden or misleading ingredients marketed for weight loss, sexual enhancement, and bodybuilding. He recounted significant regulatory actions, including a 2015 investigation by the New York State Attorney General into fraudulent supplements, which led to increased retailer-led regulations.

Steve Mister, President and CEO of the Council for Responsible Nutrition (CRN), discussed the Dietary Supplement Health and Education Act (DSHEA), which has been pivotal for the industry since its inception nearly 30 years ago. He argued against sweeping reforms, advocating instead for targeted adjustments to enhance FDA enforcement and align oversight with market growth, emphasizing the need for a unified industry approach to advocacy.

Karen Howard, CEO and Executive Director of the Organic & Natural Health Association, highlighted the organization’s focus on integrity, access, and innovation in regulatory, business, and scientific areas. She outlined efforts to improve product testing, enhance transparency, and address the health needs of minority populations, women, and children.

Loren Israelsen, President of the United Natural Products Alliance (UNPA), discussed the significant changes 2024 brought, likening it to the transformative year of 1994. He touched on the potential impacts of political changes on the industry, particularly the nomination of Robert F. Kennedy Jr. as Secretary of Health and Human Services, and the implications of the Supreme Court’s decision to end the Chevron Doctrine.

Jim Emme, CEO of NOW Health Group, shared insights on the company’s growth and the challenges and opportunities in the regulatory environment, particularly concerning the enforcement of product standards.

Karen E. Todd, Vice President of Global Brand Marketing at Kyowa Hakko USA, emphasized the shift in consumer preferences towards scientifically supported branded ingredients over generics, highlighting the importance of transparency and scientific validation in consumer choices.

Shaheen Majeed, Global CEO & Managing Director of Sabinsa Corporation, discussed the challenges and strategies in global markets, particularly around pesticide testing and promoting diversity in clinical research.

These insights collectively underscore the dynamic nature of the dietary supplement industry and the critical need for proactive engagement, regulatory vigilance, and continuous innovation to navigate the complexities of the market and regulatory environments.